drugset / Trial / NCT01820728
A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®
RandomizedParallel-groupOpen-labelTreatment
Summary
open label, active-controlled, randomized, parallel group, comparative study.
Timeline
- Start
- 2007-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-3801 | Protein / enzyme biologic | 75 iu | — |
| Comparator | Gonal-f | Protein / enzyme biologic | 75 iu | — |